Skip to main content

Table 5 AMH cut off (3.32 ng/mL) analyzed concomitantly with other ORM in parallel and in series, the prediction of amenorrhea or oligomenorrhea

From: Age, anti-müllerian hormone, antral follicles count to predict amenorrhea or oligomenorrhea after chemotherapy with cyclophosphamide

Age ≥ 32 years Parallel test Series test
  Sensivity Specificity Sensivity Specificity
AMH ≤3,32 99,4 % 26 % 81 % 80 %
AFC <13 follicles 99 % 24 % 78 % 78 %